GlaxoSmithKline Pharmaceuticals 2Q Net Profit INR1.29 Bln, Up 4%

26th Jul 2010 08:13

BANGALORE (Dow Jones)--GlaxoSmithKline Pharmaceuticals Ltd. (500660.BY) Monday posted a 4% rise in its second-quarter net profit to INR1.29 billion from INR1.24 billion a year earlier. The Indian unit of GlaxoSmithKline PLC (GSK.LN) said its sales for the three months ended June 30 rose 9% to INR4.98 billion from INR4.57 billion. The results included a one-time charge of INR106.2 million in the latest quarter, compared with INR73.1 million in the year-earlier period, the company said in a statement. -By Dhanya Ann Thoppil, Dow Jones Newswires; +91-9886929464; [email protected] Order free Annual Report for GlaxoSmithKline plc Visit http://djnweurope.ar.wilink.com/?ticker=GB0009252882 or call +44 (0)208 391 6028 (END) Dow Jones Newswires July 26, 2010 03:13 ET (07:13 GMT)